Cediranib Phase II Study in Children with Metastatic Alveolar Soft Part Sarcoma (ASPS).

BACKGROUND: ASPS, a rare vascular sarcoma with clinically indolent course, frequently presents with metastases. Vascular endothelial growth factor (VEGF) is a promising therapeutic target. In a phase II trial of the VEGF receptor inhibitor cediranib for adults with ASPS, the partial response (PR) ra...

全面介紹

Na minha lista:
書目詳細資料
發表在:Pediatr Blood Cancer
Main Authors: Cohen, Julia W., Widemann, Brigitte C., Derdak, Joanne, Dombi, Eva, Goodwin, Anne, Dompierre, Jessica, Onukwubiri, Uzoma, Steinberg, Seth M., Coyne, Geraldine O’Sullivan, Kummar, Shivaani, Chen, Alice P., Glod, John
格式: Artigo
語言:Inglês
出版: 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803032/
https://ncbi.nlm.nih.gov/pubmed/31502400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.27987
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍